Publications by authors named "Laia Simo-Riudalbas"

Claim this Profile
T
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer.
Anne I Kraemer, Chloe Chong, Florian Huber, HuiSong Pak, Brian J Stevenson

Nat Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis.
Laia Simó-Riudalbas, Sandra Offner, Evarist Planet, Julien Duc, Laurence Abrami

Nat Commun· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes.
Chloe Chong, Markus Müller, HuiSong Pak, Dermot Harnett, Florian Huber

Nat Commun· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer.
Montserrat Pérez-Salvia, Laia Simó-Riudalbas, Pere Llinàs-Arias, Laura Roa, Fernando Setien

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barcelona Conference on Epigenetics and Cancer: 50 years of histone acetylation.
Montserrat Perez-Salvia, Laia Simó-Riudalbas, Juan Ausió, Manel Esteller

Epigenetics· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer.
Laia Simó-Riudalbas, Montserrat Pérez-Salvia, Fernando Setien, Alberto Villanueva, Catia Moutinho

Cancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
Laia Simó-Riudalbas, Manel Esteller

Br J Pharmacol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer genomics identifies disrupted epigenetic genes.
Laia Simó-Riudalbas, Manel Esteller

Hum Genet· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient.
Holger Heyn, Enrique Vidal, Sergi Sayols, Jose V Sanchez-Mut, Sebastian Moran

Epigenetics· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNMT3B gene amplification predicts resistance to DNA demethylating drugs.
Laia Simó-Riudalbas, Sónia A Melo, Manel Esteller

Genes Chromosomes Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.
Sonia Melo, Alberto Villanueva, Catia Moutinho, Veronica Davalos, Riccardo Spizzo, Laia Simo-Riudalbas

Proc Natl Acad Sci U S A· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis